0.300
0.00 (0.00%)
| Previous Close | 0.300 |
| Open | 0.300 |
| Volume | 22,100 |
| Avg. Volume (3M) | 1,136,866 |
| Market Cap | 82,564,208 |
| Price / Earnings (TTM) | 30.00 |
| Price / Sales | 0.470 |
| Price / Book | 1.04 |
| 52 Weeks Range |
| Profit Margin | 1.61% |
| Operating Margin (TTM) | 1.39% |
| Diluted EPS (TTM) | 0.010 |
| Quarterly Revenue Growth (YOY) | -2.00% |
| Quarterly Earnings Growth (YOY) | -9.50% |
| Total Debt/Equity (MRQ) | 22.65% |
| Current Ratio (MRQ) | 2.22 |
| Operating Cash Flow (TTM) | 9.51 M |
| Levered Free Cash Flow (TTM) | -3.35 M |
| Return on Assets (TTM) | 2.47% |
| Return on Equity (TTM) | 3.86% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (MY) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Bearish | Mixed | |
| Stock | PLABS | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | 2.5 |
| Price Volatility | -3.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 4.0 |
| Average | 0.20 |
|
Peterlabs Holdings Bhd is a Malaysia-based company engaged in the manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis, and feed formulation. The operating segments of the group are Manufacturing which relates to the manufacturing of animal health and nutrition products, and Trading which relates to the trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplements, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally and generates key revenue from the Trading segment. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 66.94% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MR BU YAW SENG | 0.295 | - | 2,500,000 | 738,000 |
| Aggregate Net Quantity | 2,500,000 | |||
| Aggregate Net Value ($) | 738,000 | |||
| Aggregate Avg. Buy ($) | 0.295 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MR BU YAW SENG | Substantial Shareholder | 24 Apr 2025 | Acquired (+) | 600,000 | 0.300 | 180,000 |
| MR BU YAW SENG | Substantial Shareholder | 22 Apr 2025 | Acquired (+) | 500,000 | 0.290 | 145,000 |
| MR BU YAW SENG | Substantial Shareholder | 21 Apr 2025 | Acquired (+) | 1,400,000 | 0.295 | 413,000 |
| 5Y Average Dividend Yield | 1.89% |
| Payout Ratio | 38.83% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 21 Mar 2024 | 06 Mar 2024 | 29 Mar 2024 | 0.004 Cash |
| 14 Jul 2022 | 20 Jun 2022 | 22 Jul 2022 | 0.006 Cash |
| 01 Oct 2020 | 17 Sep 2020 | 09 Oct 2020 | 0.01 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 0.004 | 1 | 2.11 |
| 2022 | 0.006 | 1 | 3.08 |
| 2020 | 0.010 | 1 | 4.26 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |